Kevin T. Seltzer

Kevin T. Seltzer has a diverse work experience spanning several industries and roles. Kevin T. is currently the President, CEO, and Co-Founder of Sia - Specialty Infusion Apothecary & Wellness Spa, where they aim to revolutionize chronic illness and wellness healthcare. In this role, they focus on creating a spa-like experience for patients undergoing chronic illness treatments to improve adherence and outcomes.

Additionally, Kevin serves as the Chief Financial Officer of KAYA17, a company that has developed a rapid and accurate COVID-19 saliva test. Kevin T. is responsible for managing all finance activities, including planning, budgeting, forecasting, fundraising, data analytics, and risk management.

Previously, Kevin worked as the Chief Financial Officer of Open Systems Technologies from 2016 to 2020. Kevin T. also served as a Business Advisor, providing financial leadership to middle-market companies and assisting with financial planning and analysis, management reporting, and process enhancements.

Kevin's earlier experience includes the role of Vice President of Finance at AEA Investors LP, where they oversaw fiscal operations for various entities across multiple asset classes. Prior to this, they held positions as Senior Vice President of Finance at Blackstone, Vice President at Merrill Lynch, and Associate at Coopers & Lybrand.

Kevin T. Seltzer obtained a Juris Doctor degree with a focus on Corporate Finance and Taxation from New York Law School. Prior to that, they pursued a Bachelor of Science degree in Accounting from Long Island University. Their education journey began at Chaminade High School where they earned a General Diploma.